JournalTOCs

IN VIVO
Journal Prestige (SJR): 0.409

Citation Impact (citeScore): 1
Number of Followers: 4

Full-text available via subscription

Subscription journal
ISSN (Online) 0733-1398
Published by Informa plc

[9 journals]

Slew Of Challenges Calls For Revised Biopharma Playbook
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: While not immune to the impact of a storm of macroeconomic pressures, pharma companies have pulled through before, and they’ll... Related Stories
  The Serious Business of Digital Medical Games
  New Deals, Modalities In Sights In Japan After Relatively Quiet 2022
  The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
  PubDate: Wed, 01 Feb 2023 13:54:50 GMT
Roivant Is Striving Towards New Standards Of Care
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: With numerous highly anticipated data readouts due over 2023, the spotlight is on Roivant like never before. CEO Matt Gline... Related Stories
  The Mandate To Make A Digital Difference
  Panthera On The SMO Model, Responsible Growth Priorities And The Hybridized Trial Of The Future
  Rocket Pharmaceuticals’ CEO Talks Gene Platforms and Spiritual Leadership
  PubDate: Wed, 01 Feb 2023 13:43:15 GMT
The Mandate To Make A Digital Difference
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: Diogo Rau, chief information and digital officer at Lilly, talks to In Vivo about the company’s plans for making big... Related Stories
  Roivant Is Striving Towards New Standards Of Care
  Panthera On The SMO Model, Responsible Growth Priorities And The Hybridized Trial Of The Future
  Rocket Pharmaceuticals’ CEO Talks Gene Platforms and Spiritual Leadership
  PubDate: Wed, 01 Feb 2023 13:41:56 GMT
Snapshot: January Highlights
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: A selection of articles you may have missed from January 2023, covering the FDA?s approach to gene therapies and their... Related Stories
  Deals Shaping The Medical Industry, December 2022
  Pandemic Drives China Surge In Asia 100 Sales
  Snapshot: November Highlights
  PubDate: Wed, 01 Feb 2023 13:41:16 GMT
The Serious Business Of Digital Medical Games
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: There are fewer than a handful of approved prescription video game digital therapeutics, but gamification in patient care is proving... Related Stories
  New Deals, Modalities In Sights In Japan After Relatively Quiet 2022
  The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
  Teva’s New CEO Francis: No Revolution, But New Strategy Will Not Be Marginal
  PubDate: Wed, 25 Jan 2023 14:45:48 GMT
Panthera On The SMO Model, Responsible Growth Priorities And The
Hybridized Trial Of The Future
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: In this episode of the In Vivo podcast, Jo Shorthouse speaks with the co-founder and chief commercial officer of the... Related Stories
  Rocket Pharmaceuticals’ CEO Talks Gene Platforms and Spiritual Leadership
  The Secret Sauce to BenevolentAI’s Ongoing Success
  FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development
  PubDate: Wed, 25 Jan 2023 13:59:01 GMT
New Deals, Modalities In Sights In Japan After Relatively Quiet 2022
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: After a comparatively subdued 2022 in terms of M&A and other deal-making, a strengthening currency and interest in new areas... Related Stories
  The Serious Business of Digital Medical Games
  The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
  Teva’s New CEO Francis: No Revolution, But New Strategy Will Not Be Marginal
  PubDate: Wed, 25 Jan 2023 13:39:00 GMT
The E in ESG: Medtechs Are Getting To Grips With The ‘True
Purpose’ Of Carbon Zero
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities... Related Stories
  The Serious Business of Digital Medical Games
  New Deals, Modalities In Sights In Japan After Relatively Quiet 2022
  Teva’s New CEO Francis: No Revolution, But New Strategy Will Not Be Marginal
  PubDate: Wed, 25 Jan 2023 13:39:00 GMT
Teva’s New CEO Francis: No Revolution, But New Strategy Will Not Be
Marginal
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: On the final day of the annual J.P. Morgan Healthcare Conference, Richard Francis, with vast experience at Biogen and Sandoz... Related Stories
  Deals In Depth: December 2022
  How Boehringer Ingelheim Deepened Its Digital Transformation
  Building The Pharma Supply Chain Of The Future
  PubDate: Mon, 23 Jan 2023 16:31:00 GMT
Deals In Depth: December 2022
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: The year?s biggest M&A deal, along with billion dollar alliances marked out December?s dealmaking credentials. Related Stories
  How Boehringer Ingelheim Deepened Its Digital Transformation
  Building The Pharma Supply Chain Of The Future
  Organs On Chips: The Silver Bullet Pharma Is Priming To Fire
  PubDate: Mon, 23 Jan 2023 13:57:17 GMT
The Role Of Data Encryption In Cyber Attacks
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: The health care and pharma industries are particularly vulnerable to a cyber-attack, also experiencing the highest cost of a breach... Related Stories
  Informing Treatment Decisions in Psoriatic Arthritis: The Value of Network Meta-Analyses
  The Cell And Gene Therapy Sector In 2023: A Wave Is Coming – Are We Ready?
  Dark Territory: Lifting The Veil On GPOs And PBMs
  PubDate: Mon, 23 Jan 2023 13:56:25 GMT
In Vivo’s Deals Of The Year: Cast Your Vote!
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: It is time for In Vivo?s 15th annual Deals of the Year contest. We?ve selected 15 nominees across three categories... Related Stories
  In Vivo’s Deals Of The Year: Cast Your Vote!
  Califf: Decades Of Follow-Up Necessary For Gene Therapy
  Execs On The Move: January 2022
  PubDate: Thu, 19 Jan 2023 02:38:29 GMT
How Boehringer Ingelheim Deepened Its Digital Transformation
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: While many pharma companies have integrated digital tools like cloud services into their operations, some are later adopters. Boehringer Ingelheim... Related Stories
  Building The Pharma Supply Chain Of The Future
  Organs On Chips: The Silver Bullet Pharma Is Priming To Fire
  Worldwide Regulators Warm Up To Medical Marijuana
  PubDate: Wed, 18 Jan 2023 13:53:40 GMT
Califf: Decades Of Follow-Up Necessary For Gene Therapy
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: FDA Commissioner Califf acknowledges that regulatory pathways for gene therapies are still being developed and that many factors outside of... Related Stories
  In Vivo’s Deals Of The Year: Cast Your Vote!
  Execs On The Move: January 2022
  GE HealthCare Stretches To The Next Level
  PubDate: Wed, 18 Jan 2023 13:35:00 GMT
Rocket Pharmaceuticals’ CEO Talks Gene Platforms and Spiritual
Leadership
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: The trajectory of Rocket Pharmaceuticals, a clinical-stage gene therapy company, has been marked by a series of impressive milestones. At... Related Stories
  The Secret Sauce to BenevolentAI’s Ongoing Success
  FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development
  Flight Of The Navigator: Bluebird bio?s Andrew Obenshain
  PubDate: Wed, 18 Jan 2023 13:32:44 GMT
Deals Shaping The Medical Industry, December 2022
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: In Vivo?s deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro... Related Stories
  Pandemic Drives China Surge In Asia 100 Sales
  Snapshot: November Highlights
  Deals Shaping The Medical Industry, October 2022
  PubDate: Mon, 16 Jan 2023 09:26:49 GMT
Execs On The Move: December 2022
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries. Related Stories
  In Vivo’s Deals Of The Year: Cast Your Vote!
  Califf: Decades Of Follow-Up Necessary For Gene Therapy
  Execs On The Move: January 2022
  PubDate: Mon, 16 Jan 2023 09:25:57 GMT
The Secret Sauce To BenevolentAI’s Ongoing Success
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: In a crowded AI-driven drug development sector, BenevolentAI stands out with its broad pipeline of drug candidates, deep pockets, and... Related Stories
  FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development
  Flight Of The Navigator: Bluebird bio?s Andrew Obenshain
  Lessons From Novo Nordisk’s Mads Øvlisen, The Father Of CSR
  PubDate: Mon, 16 Jan 2023 09:24:55 GMT
Building The Pharma Supply Chain Of The Future
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: The worst of COVID-19’s disruption appears to be in the pharma supply chain’s rearview mirror, but logistics stakeholders still have... Related Stories
  Organs On Chips: The Silver Bullet Pharma Is Priming To Fire
  Worldwide Regulators Warm Up To Medical Marijuana
  Uncertainty Clouds Pharma Patent Validity As SCOTUS Ruminates On Amgen Case
  PubDate: Thu, 12 Jan 2023 04:02:31 GMT
Organs On Chips: The Silver Bullet Pharma Is Priming To Fire
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Abstract: In this two-part series, In Vivo will explore why organ on chip technology exists, the factors driving and limiting their... Related Stories
  Building The Pharma Supply Chain Of The Future
  Organs On Chips: The Silver Bullet Pharma Is Priming To Fire
  Worldwide Regulators Warm Up To Medical Marijuana
  PubDate: Thu, 12 Jan 2023 04:01:41 GMT